Amplitude integrated electroencephalography as a prognostic value of neurodevelopment in preterm newborns.

Study type

• Study type:
  Clinical trial
• Scope of the study:
  Assessment of risk minimisation measure implementation or effectiveness

Clinical trials

• Clinical trial randomisation:
  Non-randomised clinical trial

Population studied

• Age groups:
  • Preterm newborn infants (0 – 27 days)
• Estimated number of subjects:
  200

Study design details

• Main study objective:
  The aim of our study is to determine the prognostic value of amplitude integrated electroencephalography recorded during the neonatal period for the psychomotor development of very preterm infants at the 12-month corrected age.
• Data analysis plan:
  Amplitude integrated electroencephalography has a high predictive value for both short-term and long-term outcome. It will be possible to provide more help for family of the premature baby, to refer to appropriate professionals. Amplitude electroencephalography provides a minimal intervention outcomes. Subjects will not be given any additional medications. To keep the study confidential, subjects will be given an identification number.